Department of Public Health Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia.
National Cancer Registry, National Cancer Institute, 62250 Putrajaya, Malaysia.
Asian Pac J Cancer Prev. 2022 Jun 1;23(6):1885-1892. doi: 10.31557/APJCP.2022.23.6.1885.
Colorectal cancer is a major public health problem with significant number of cases and death in the population. This study aimed to determine the 5-year overall survival rate and the prognostic factors for colorectal cancer patients in Sabah.
This was a retrospective cohort study conducted using secondary data from Malaysian National Cancer Registry (MNCR) database. A 5-year overall survival and the median survival time were determined with Kaplan-Meier survival curve. Cox regression analysis was done to determine the prognostic factors on survival.
A total of 1,152 patients were included in this study. The majority of the patients had colon cancer and presented at late stage (stage III and IV) as compared to early stage (stage I and II). From the analysis, the 5-year overall survival for colorectal cancer was 23.2% (95% CI: 21.8, 24.6) and the median survival time was 16 months (95% CI: 14.3, 17.7). Higher survivals are seen in males (23.6%, 95% CI: 20.4, 24.7), aged 50-74 years old (24.2%, 95% CI: 22.4, 26.0), Chinese (25.5%, 95% CI: 23.0, 28.0), lived in Keningau (25.6%, 95% CI: 20.8, 30.4), colon as primary tumor site (24.5%, 95% CI: 22.5, 26.4), diagnosed with stage I (55.6%, 95% CI: 48.7, 62.5) and received surgery with chemotherapy or radiotherapy (31.3%, 95% CI: 27.8, 34.8). The significant prognostic factor was the stage at diagnosis. Patients with stage IV colorectal cancer (HR: 11.18; 95% CI: 3.48, 35.93) had eleven times risk of dying as compared to stage I.
The survival rate for colorectal cancer patients in Sabah was comparatively lower than other states in Malaysia and in some Asian countries. Those patients who presented at later stage had poorer survival. Health promotion and community-based screening program should be emphasized in addition to encouraging early diagnosis to improve survival.
结直肠癌是一个重大的公共卫生问题,在人群中有大量的病例和死亡。本研究旨在确定沙巴的结直肠癌患者的 5 年总生存率和预后因素。
这是一项使用马来西亚国家癌症登记处(MNCR)数据库的二级数据进行的回顾性队列研究。使用 Kaplan-Meier 生存曲线确定 5 年总生存率和中位生存时间。进行 Cox 回归分析以确定生存的预后因素。
共有 1152 名患者纳入本研究。与早期阶段(I 期和 II 期)相比,大多数患者患有结肠癌且处于晚期(III 期和 IV 期)。分析显示,结直肠癌的 5 年总生存率为 23.2%(95%CI:21.8,24.6),中位生存时间为 16 个月(95%CI:14.3,17.7)。男性(23.6%,95%CI:20.4,24.7)、50-74 岁(24.2%,95%CI:22.4,26.0)、华人(25.5%,95%CI:23.0,28.0)、居住在京那巴鲁(25.6%,95%CI:20.8,30.4)、结肠为原发肿瘤部位(24.5%,95%CI:22.5,26.4)、诊断为 I 期(55.6%,95%CI:48.7,62.5)和接受手术联合化疗或放疗(31.3%,95%CI:27.8,34.8)的患者存活率较高。显著的预后因素是诊断时的分期。与 I 期相比,IV 期结直肠癌患者(HR:11.18;95%CI:3.48,35.93)死亡风险高 11 倍。
沙巴的结直肠癌患者的生存率低于马来西亚其他州和一些亚洲国家。那些处于晚期的患者生存率较差。除了鼓励早期诊断以提高生存率外,还应强调开展健康促进和社区为基础的筛查计划。